Tocilizumab in Extracranial Giant-Cell Arteritis and Takayasu Arteritis: A Multicentric Observational Comparative Study

Tocilizumab (TCZ) has demonstrated potential efficacy in managing large-vessel (LV) vasculitis such as giant-cell arteritis (GCA) and Takayasu arteritis (TAK). Despite the shared characteristics between the LV-GCA phenotype and TAK, there are differences between both entities that may affect therape...

Full description

Bibliographic Details

Published in:	Sci
Main Authors:	Carmen Lasa-Teja, Javier Loricera, Diana Prieto-Peña, Fernando López-Gutiérrez, Pilar Bernabéu, María Mercedes Freire-González, Beatriz González-Alvarez, Roser Solans-Laqué, Mauricio Mínguez, Iván Ferraz-Amaro, Santos Castañeda, Ricardo Blanco, on behalf of the Tocilizumab in Large-Vessel Vasculitis Spanish Collaborative Group
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Subjects:	tocilizumab Takayasu’s arteritis giant-cell arteritis large-vessel vasculitis
Online Access:	https://www.mdpi.com/2413-4155/7/1/12